ICERM Workshop 2012
Ligand Dynamics in Heme Proteins Ligand Dynamics in Heme Proteins - - PowerPoint PPT Presentation
Ligand Dynamics in Heme Proteins Ligand Dynamics in Heme Proteins - - PowerPoint PPT Presentation
Ligand Dynamics in Heme Proteins Ligand Dynamics in Heme Proteins Markus Meuwly Department of Chemistry University of Basel ICERM Workshop 2012 Overview Overview Introduction and Computational Techniques Applications Smoluchowski
ICERM Workshop 2012
Overview Overview
- Introduction and Computational Techniques
- Applications
- Smoluchowski Treatment
- Transition Networks
- Protein- and Ligand-Motion
- Spatial Averaging
- Summary
ICERM Workshop 2012
Overview Overview Small ligands play important functional roles in proteins. Heme-proteins (Mb, Hb, Ngb, trHb, etc.) bind ligands such as O2, NO, CO with various purposes:
- Transport
- Removal of NO
- Neurotransmission, Vasodilation
Fundamental questions:
- How do these molecules enter their host proteins
- How do they move (cavities)
- How do they bind (allostery)
ICERM Workshop 2012
Overview Overview
The goal is to understand in general terms the processes of ligand dissociation, rebinding, recognition, and discrimination, and to explore ligand entrance and exit pathways in the framework of protein structure and dynamics, using myoglobin as a specific example. Comprehensive studies have been carried out over the time scale from femtoseconds to seconds, under a broad range of experimental conditions such as temperature, pressure, solvent viscosity, and pH, for several species of wild-type myoglobins and for variants of important amino acid residues. [Moffat, Biochem. (2001)] Our experiment shows that the pathway of a small molecule in its trajectory through a protein may be modified by site-directed mutagenesis, and that migration within the protein matrix to the active site involves a limited number of pre-existing cavities identified in the interior space of the protein. [Schlichting, PNAS (2000)]
ICERM Workshop 2012
Ligand Dynamics in Heme-Proteins: The Bohr-effect Ligand Dynamics in Heme-Proteins: The Bohr-effect
Affinity (binding capacity) of Hb depends on pH and [CO2]. Low pH/high [CO2] leads to reduced O2 affinity; i.e. regulation R-state: relaxed, 6- coordinated structure, high- O2-affinity T-state: tense, 5- coordinated structure, low- O2-affinity
ICERM Workshop 2012
Ligand Dynamics in Heme-Proteins Ligand Dynamics in Heme-Proteins Time scales for ligand motion “Logic” of ligand migration Comparison with experiment Protein- and ligand-motion
Schulten et al., Biophys. J. (2006) Maragliano et al., JACS (2010)
ICERM Workshop 2012
Introduction: Protein Structure and Ligand Diffusion Introduction: Protein Structure and Ligand Diffusion
- F. Schotte et al., Science 300, 1944 (2003)
ICERM Workshop 2012
Introduction: Role of Simulations Introduction: Role of Simulations Understanding of, providing insights into and making predictions about mechanisms at molecular level. MD with improved/modified FFs
- Relationship between structure, dynamics and spectroscopy?
- What do ligands tell us about protein interiors?
ICERM Workshop 2012
Introduction and Computational Techniques Introduction and Computational Techniques Intermolecular interactions Diffusive Dynamics Chemical Reactions
- Fluctuating Charge Models
- Multipolar Force Fields
- Dissociative Force Fields
- Morphing Potentials
- Solving Smoluchowski
Equations on Rough Surfaces
- Transition Networks
- Reactive MD
- Dissociative Force Fields
ICERM Workshop 2012
Computational Techniques: Force Fields Computational Techniques: Force Fields
Force Field:
Atom-based energy expression Etot=Ebond+Enonbond
Bonded Terms
Bond Energies E = ½ k (x-xe)2 Angle Energies E = ½ k (-e)2 Torsion Energies E = Vn cos(n-e)2
Nonbonded Terms
Coulomb Eij = qiqj/40r Van der Waals Eij = 4ij (ij
12-ij 6)
ij= sqrt(i j ) ij=(rij/ij) ij=1/2(i +j) x qi qi qj
ICERM Workshop 2012
Molecular Simulations Molecular Simulations
Given a way to compute the interaction energy V (e.g. force field, quantum, semiempirical)
- f a system it is then possible to determine physico-chemical properties from a molecular
simulation. The result will be a trajectory Using statistical mechanics, numerous experimental observables can be computed: Accuracy of the intermolecular interactions and the degree of sampling of the configurational space determine the quality of a simulation (and the observables derived from it).
x x F V t m
t t v x ;
Temperature Specific heat Diffusion coefficient Infrared spectrum
NVT B V
E T k C
2 2
1
N i i i B B
m Nk Nk K T
1 2
3 1 3 2 p
3 1 t dt D
i i
v v
t t i dt I μ μ 0
exp
ICERM Workshop 2012
Mb: Ligand Rebinding in MbCO (100 ns rebinding) Mb: Ligand Rebinding in MbCO (100 ns rebinding)
10 8 6 4 2 5 – 5 – 10 – 15 – 20 DP A Xe4(2) Xe4(1) R/A G(kcal/mol) DP Xe4(1) Xe4(2) A Fe 4 1 –2 –3 10 6 2 – 6 – 4 – 2 4 8 v/A 2 10 6 2 – 6 – 4 – 2 4 8 v/A X X Fe 5 – 13 – 9 – 5 – 1 1 3 u/A
Banushkina and Meuwly, JCTC, 2, 208 (2005); JPCB, 109, 16911 (2005); JCP (2007)
ICERM Workshop 2012
Smoluchowski simulation of protein folding based on pre-calculated FES.
U F
Sheinerman and Brooks, PNAS (1998) Roder et al., Nat. Struc. Biol. (1999)
MD simulations of protein G in explicit solvent. Experimental folding times: 600 – 700 s 2-30 ms (denaturant dependent)
Solving Smoluchowski Equations on Rough Potentials
SE difficult to solve on rough PESs Use of Hierarchical Discrete Approximation:1 Introduce a hierarchy of grids
1 Banushkina and Meuwly, JCTC, 2, 218 (2005)
Solving Smoluchowski Equations on Rough Potentials
ICERM Workshop 2012
Having a procedure to solve SEs on rough PESs we can no pre-compute the free energy surface for ligand motion and avoid the long-time scale problem present in explicit sampling. From several independent trajectories this FES can be constructed efficiently.
ICERM Workshop 2012
10 8 6 4 2 5 – 5 – 10 – 15 – 20 DP A Xe4(2) Xe4(1) R/A G(kcal/mol) DP Xe4(1) Xe4(2) A Fe 4 1 –2 –3 10 6 2 – 6 – 4 – 2 4 8 v/A 2 10 6 2 – 6 – 4 – 2 4 8 v/A X X Fe 5 – 13 – 9 – 5 – 1 1 3 u/A
Solving Smoluchowski Equations on Rough Potentials
ICERM Workshop 2012
Myoglobin: Smoluchowski Simulations Myoglobin: Smoluchowski Simulations
t = 0.5 ps
9.0 8.0 7.0 6.0 5.0 4.0 3.0 2.0 1.0 0.0 – 1.0 – 2.0 – 3.0 – 4.0 – 12 – 10 – 8 – 6 – 4 –2 2 4 u/Angstrom v/Angstrom
ICERM Workshop 2012
Myoglobin: Smoluchowski Simulations Myoglobin: Smoluchowski Simulations
9.0 8.0 7.0 6.0 5.0 4.0 3.0 2.0 1.0 0.0 – 1.0 – 2.0 – 3.0 – 4.0 – 12 – 10 – 8 – 6 – 4 –2 2 4 u/Angstrom v/Angstrom
t = 1.0 ps
ICERM Workshop 2012
Myoglobin: Smoluchowski Simulations Myoglobin: Smoluchowski Simulations
9.0 8.0 7.0 6.0 5.0 4.0 3.0 2.0 1.0 0.0 – 1.0 – 2.0 – 3.0 – 4.0 – 12 – 10 – 8 – 6 – 4 –2 2 4 u/Angstrom v/Angstrom
t = 2.5 ps
ICERM Workshop 2012
Myoglobin: Smoluchowski Simulations Myoglobin: Smoluchowski Simulations
9.0 8.0 7.0 6.0 5.0 4.0 3.0 2.0 1.0 0.0 – 1.0 – 2.0 – 3.0 – 4.0 – 12 – 10 – 8 – 6 – 4 –2 2 4 u/Angstrom v/Angstrom
t = 5.0 ps
ICERM Workshop 2012
Myoglobin: Smoluchowski Simulations Myoglobin: Smoluchowski Simulations
9.0 8.0 7.0 6.0 5.0 4.0 3.0 2.0 1.0 0.0 – 1.0 – 2.0 – 3.0 – 4.0 – 12 – 10 – 8 – 6 – 4 –2 2 4 u/Angstrom v/Angstrom
t = 25.0 ps
ICERM Workshop 2012
Myoglobin: Smoluchowski Simulations Myoglobin: Smoluchowski Simulations
9.0 8.0 7.0 6.0 5.0 4.0 3.0 2.0 1.0 0.0 – 1.0 – 2.0 – 3.0 – 4.0 – 12 – 10 – 8 – 6 – 4 –2 2 4 u/Angstrom v/Angstrom
t = 50.0 ps
ICERM Workshop 2012
Myoglobin: Smoluchowski Simulations Myoglobin: Smoluchowski Simulations
9.0 8.0 7.0 6.0 5.0 4.0 3.0 2.0 1.0 0.0 – 1.0 – 2.0 – 3.0 – 4.0 – 12 – 10 – 8 – 6 – 4 –2 2 4 u/Angstrom v/Angstrom
t = 100 ps
ICERM Workshop 2012
Myoglobin: Smoluchowski Simulations Myoglobin: Smoluchowski Simulations
9.0 8.0 7.0 6.0 5.0 4.0 3.0 2.0 1.0 0.0 – 1.0 – 2.0 – 3.0 – 4.0 – 12 – 10 – 8 – 6 – 4 –2 2 4 u/Angstrom v/Angstrom
t = 250 ps
ICERM Workshop 2012
Myoglobin: Smoluchowski Simulations Myoglobin: Smoluchowski Simulations
9.0 8.0 7.0 6.0 5.0 4.0 3.0 2.0 1.0 0.0 – 1.0 – 2.0 – 3.0 – 4.0 – 12 – 10 – 8 – 6 – 4 –2 2 4 u/Angstrom v/Angstrom
t = 500 ps
ICERM Workshop 2012
Myoglobin: Smoluchowski Simulations Myoglobin: Smoluchowski Simulations
9.0 8.0 7.0 6.0 5.0 4.0 3.0 2.0 1.0 0.0 – 1.0 – 2.0 – 3.0 – 4.0 – 12 – 10 – 8 – 6 – 4 –2 2 4 u/Angstrom v/Angstrom
t = 1.0 ns
ICERM Workshop 2012
Myoglobin: Smoluchowski Simulations Myoglobin: Smoluchowski Simulations
9.0 8.0 7.0 6.0 5.0 4.0 3.0 2.0 1.0 0.0 – 1.0 – 2.0 – 3.0 – 4.0 – 12 – 10 – 8 – 6 – 4 –2 2 4 u/Angstrom v/Angstrom
t = 2.5 ns
ICERM Workshop 2012
Myoglobin: Smoluchowski Simulations Myoglobin: Smoluchowski Simulations
9.0 8.0 7.0 6.0 5.0 4.0 3.0 2.0 1.0 0.0 – 1.0 – 2.0 – 3.0 – 4.0 – 12 – 10 – 8 – 6 – 4 –2 2 4 u/Angstrom v/Angstrom
t = 10.0 ns
ICERM Workshop 2012
Myoglobin: Smoluchowski Simulations Myoglobin: Smoluchowski Simulations
9.0 8.0 7.0 6.0 5.0 4.0 3.0 2.0 1.0 0.0 – 1.0 – 2.0 – 3.0 – 4.0 – 12 – 10 – 8 – 6 – 4 –2 2 4 u/Angstrom v/Angstrom
t = 100 ns
ICERM Workshop 2012
Myoglobin: Smoluchowski Simulations Myoglobin: Smoluchowski Simulations
9.0 8.0 7.0 6.0 5.0 4.0 3.0 2.0 1.0 0.0 – 1.0 – 2.0 – 3.0 – 4.0 – 12 – 10 – 8 – 6 – 4 –2 2 4 u/Angstrom v/Angstrom
t = 250 ns
ICERM Workshop 2012
Myoglobin: Smoluchowski Simulations Myoglobin: Smoluchowski Simulations
9.0 8.0 7.0 6.0 5.0 4.0 3.0 2.0 1.0 0.0 – 1.0 – 2.0 – 3.0 – 4.0 – 12 – 10 – 8 – 6 – 4 –2 2 4 u/Angstrom v/Angstrom
t = 500 ns
ICERM Workshop 2012
Myoglobin: Smoluchowski Simulations Myoglobin: Smoluchowski Simulations
9.0 8.0 7.0 6.0 5.0 4.0 3.0 2.0 1.0 0.0 – 1.0 – 2.0 – 3.0 – 4.0 – 12 – 10 – 8 – 6 – 4 –2 2 4 u/Angstrom v/Angstrom
t = 1000 ns
ICERM Workshop 2012
Myoglobin: Ligand Rebinding in MbCO Myoglobin: Ligand Rebinding in MbCO
Independent validation: Inner barrier 4.3 kcal/mol vs 4.5 kcal/mol from experiment
(kcal/mol) ns 4.0 100 5.0 280 7.5 1770
Only free parameter is . Experiment:
ns 300
1e+08
From Xe4
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 0.1 1 10 100 1000 10000 1e+05 1e+06 1e+07
normalized population time (ps) p (A) p (B) p (Xe4) R(Fe-X) Energy
B A
Steinbach et al., Biochem. (1991)
ICERM Workshop 2012
Ligand Rebinding Experiments Ligand Rebinding Experiments
A, B, Xe4 Ostermann et al., Nature, 404, 205 (2000) A, B, Xe4, Xe1, B Frauenfelder et al., PNAS, 98, 2370 (2001) Nienhaus et al., Biochem., 42, 9647 (2003) A, B, Xe4, Xe3, Xe1 Bossa et al., Biophys. J., 87, 1537 (2004) A, B, Xe1 Srajer et al., Biochem, 40, 13802 (2001) A, B, C competing with A, B, S Scott+Gibson, Biochem., 36, 11909 (1997)
S B S Xen Xe4 Mb A1 A3 A0 Xe1
ICERM Workshop 2012
Ligand Rebinding Experiments Ligand Rebinding Experiments
50 K 60 K 70 K 80 K 100 K 120 K 140 K 160 K 190K 200 K 300 K
- 1.2
- 1.0
- 0.8
- 0.6
- 0.4
- 0.2
0.0
- 1.8
- 1.4
- 1.2
- 0.6
- 0.4
- 0.2
0.0
- 0.8
- 1.0
- 1.6
- 7
- 6
- 5
- 4
- 3
- 2
- 1
1 2 2110 2120 2130 2140 2150 2160
log N(t) log (t(s)) Wavenumber (cm-1)
a b c d
B2 B3 C B2 A B3 HB2A kB2B3 kB3B2 HB2B3 HB3B2
rc H A, B, Xe4 Ostermann et al., Nature, 404, 205 (2000)
ICERM Workshop 2012
Transition Networks Transition Networks
Prinz et al., JCP (2011) Glen et al., JCP (2010)
For complex processes/systems a statistical approach is desirable.
- No exhaustive sampling (MD, MC) possible
- Focuses on relevant ‘states’
- Close to actual experiments (endpoints, intermediates)
Markov Chains are well developed theory. Problems
- Choice of ‘coordinates’
- Definition of ‘states’ (clustering algorithms)
- Choice of time step (balance between temporal resolution and exhaustive sampling)
Definition of Markov process: current state p(t) only depends on previous state p(t-1) where t is a discrete variable. Usually describable through a transition matrix T which defines probability for transition between all states the system contains.
ICERM Workshop 2012
Transition Networks Transition Networks
The transition matrix contains all information about the system’s evolution
- n a given time scale.
nn n n
T T T T T T T T T
1 31 21 1 13 12 11
...
Prinz et al., JCP (2011) Glen et al., JCP (2010)
ICERM Workshop 2012
Nitric Oxide Diffusion Network in trHb Nitric Oxide Diffusion Network in trHb
Mishra and Meuwly, Biophys. J., (2009)
Question
Ligand diffusion network relevant to reactions.
ICERM Workshop 2012 Mishra and Meuwly, Biophys. J. (2009)
NO in trHbN: Ligand Diffusion Network and Detoxification NO in trHbN: Ligand Diffusion Network and Detoxification
ICERM Workshop 2012 Guertin et al. Proc. Nat. Acad. Sci. U.S.A. 2002, 99, 5902–5907 Mishra and Meuwly, JACS (2010)
NO in trHbN: Ligand Diffusion Network and NO Dioxygenation NO in trHbN: Ligand Diffusion Network and NO Dioxygenation
Proposed reaction scheme (Mycobacterium tuberculosis) (I) Fe(II)-O2 + NO Fe(III)-OONO (II) Fe(III)-OONO Fe(IV)-O + NO2 (III) Fe(IV)-O + NO2 Fe(III)-ONO2 (IV)Fe(III)-ONO2 Fe+(III) + NO3
- Overall rate:
7.5 10-8 M-1s-1[1] individual reactive steps with ps to ns rates ideal for ARMD studies Problem: NO2 was never observed Alternative pathway is a reorientation reaction after step (I)
ICERM Workshop 2012 Mishra and Meuwly, Biophys. J. (2009)
NO in trHbN: Ligand Diffusion Network and NO Dioxygenation NO in trHbN: Ligand Diffusion Network and NO Dioxygenation
ICERM Workshop 2012
NO in trHbN: Ligand Diffusion Network and Detoxification NO in trHbN: Ligand Diffusion Network and Detoxification
Mishra and Meuwly Biophys. J. (2009), JACS (2010) Cazade and Meuwly, ChemPhysChem (2012)
Population decay and double exponential fit Explicit simulations can be represented as a double exponential decay for the metastable states
ICERM Workshop 2012
Markov Processes Markov Processes
Noe and Fischer, Curr. Op. Struct. Biol. (2008)
t T t p p
i ~ 1: fast modes i ~ 0: slow modes T is transition matrix; constructed from MD simulation and network of states Eigenvalues and Eigenvectors of T represent time scales and transition modes between the states. Typically, one considers the ‘implied time scale’ of a transition mode i: The state of the system at time is determined according to:
i i
ln
*
j ij ij ij
C C T
Transition matrices from number of observed transitions within .
ICERM Workshop 2012
TrHbN: Markov Model TrHbN: Markov Model
Black: Tij > 0.9 Blue: Tij > 0.7 Green: Tij > 0.5 t = 1ps
ICERM Workshop 2012
Black: Tij > 0.9 Blue: Tij > 0.7 Green: Tij > 0.5 t = 10 ps
TrHbN: Markov Model TrHbN: Markov Model
ICERM Workshop 2012
Black: Tij > 0.9 Blue: Tij > 0.7 Green: Tij > 0.5 t = 50 ps
TrHbN: Markov Model TrHbN: Markov Model
ICERM Workshop 2012
Black: Tij > 0.9 Blue: Tij > 0.7 Green: Tij > 0.5 t = 100 ps
TrHbN: Markov Model TrHbN: Markov Model
ICERM Workshop 2012
Black: Tij > 0.9 Blue: Tij > 0.7 Green: Tij > 0.5 t = 200 ps
TrHbN: Markov Model TrHbN: Markov Model
ICERM Workshop 2012
Black: Tij > 0.9 Blue: Tij > 0.7 Green: Tij > 0.5 t = 500 ps
TrHbN: Markov Model TrHbN: Markov Model
ICERM Workshop 2012
NO in trHbN: Transition Matrices NO in trHbN: Transition Matrices
Mishra and Meuwly
- Biophys. J. (2010), JACS (2010)
Black: Tij > 0.9 Blue: Tij > 0.7 Green: Tij > 0.5
ICERM Workshop 2012
NO in trHbN: Ligand Diffusion Network and Detoxification NO in trHbN: Ligand Diffusion Network and Detoxification
Mishra and Meuwly Biophys. J. (2009), JACS (2010) Glen et al., J. Chem. Phys. (2010)
- First eigenvalue is stationary
solution
- Primarily population of Water (WAT)
- Gap between EVs 3 and 4 suggests
2 metastable states
- Sign structure of EVs suggests that
they include (Protein,WAT) and (PDS/WAT, protein)
ICERM Workshop 2012
NO in trHbN: Ligand Diffusion Network and Detoxification NO in trHbN: Ligand Diffusion Network and Detoxification
Mishra and Meuwly Biophys. J. (2009), JACS (2010) Keller et al., Chem. Phys. (2012)
Ultimate test for Markovianity is comparison with explicit MD simulation. Present results do not support Markovian nature on ps time scales.
ICERM Workshop 2012
NO in trHbN: Ligand Diffusion Network and Detoxification NO in trHbN: Ligand Diffusion Network and Detoxification
Mishra and Meuwly. Biophys. J. (2010), JACS (2010) Srajer et al., Biochemistry. (2001) 46:13802-15.
ICERM Workshop 2012
How do Ligands Move in Proteins? How do Ligands Move in Proteins?
Schotte et al., Science (2003) Srajer et al., Biochemistry. (2001) 46:13802-15. Plattner and Meuwly, Biophys. J. (2011)
Different possible migration pathways, i.e. network Experimentally difficult/impossible to distinguish Transport active or passive?
ICERM Workshop 2012
How do Ligands Move in Proteins? How do Ligands Move in Proteins?
Plattner and Meuwly, Biophys. J. (2011)
Sensitivity of free energy barrier to initial structure Different “preparations” – equally probable configurations from equilibrium simulations.
ICERM Workshop 2012
How do Ligands Move in Proteins? How do Ligands Move in Proteins?
Plattner and Meuwly, Biophys. J. (2011)
Conformationally averaged RMSD between two different initial structures along Xe4/Xe2 transition; dark blue, light blue, yellow, orange, red
ICERM Workshop 2012
MC for Physical and Chemical Problems
Random walks (e.g. Metropolis sampling) provide a suitable method for sampling free energy surfaces Problem: Sample disconnected importance regions in a system For a system with two importance regions separated by a high barrier, the random walk is trapped for a long time in the initial region. Reaching the second importance region requires very long sampling times. Typical remedies: umbrella sampling; parallel tempering (plus variants)
V(x) x
- N. Metropolis, et al. J. Chem. Phys., 21, 1087, (1953)
ICERM Workshop 2012
Spatial Averaging
Modify underlying probability distribution itself.
Create a family of related densities that are useful in treating the rare event problem
The integral of the modified density over all space is identical to that of the original distribution b a
x y
a b
x y
dx x dx x dy y x V y P x x V x
, , exp , exp ,
Density for a double well potential with =0, =0.2 and =0.4
Doll et al., JCP (2009); Plattner et al., JCP (2010)
ICERM Workshop 2012
Spatial Averaging: Diffusion on a Rough Surface
CO on a rough - amorphous - ice surface (interstellar chemistry)
Doll et al., JCP (2009); Plattner et al., JCP (2010)
ICERM Workshop 2012
Spatial Averaging: Diffusion on a Rough Surface
CO on a rough - amorphous - ice surface (interstellar chemistry)
[We,Ne] = [0.0,1] [We,Ne] = [0.1,10] [We,Ne] = [0.3,10] [We,Ne] = [0.5,10]
Computation of observables requires unbiasing (see posters by F. Hedin) Current investigations include (LJ)n clusters and ligand access to trHbN
Doll et al., JCP (2009); Plattner et al., JCP (2010)
ICERM Workshop 2012
Summary Summary
Coarse grained approaches in space (Smoluchowski) and time (TNA) are valuable tools to analyze ligand motion. TNA useful because states are known approximately a priori (cavities). Markovianity for ligand migration in proteins on ps time scale? Smoluchowski useful for kinetics/barriers. Protein and ligand motion probably coupled.
ICERM Workshop 2012
Acknowledgement Acknowledgement
Swiss National Science Foundation NCCR MUST Centro Svizzero di Calcolo Scientifico (CSCS)
ICERM Workshop 2012
Acknowledgement Acknowledgement
ICERM Workshop 2012
Acknowledgement: The Group Acknowledgement: The Group
- Dr. Sven
Lammers Franziska Schmid
- Dr. Jonas
Danielsson Stephan Lutz Nuria Plattner
- Dr. Ivan Tubert-
Brohman
- Dr. Michael
Devereux Manuela Koch Frida Thorsteinsdottir` Jing Huang
- Dr. Sabyashachi
Mishra Tobias Schmidt